BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
5/6/2026 8:34:26 AM | Browse: 3 | Download: 14
 |
Received |
|
2026-01-09 09:59 |
|
Peer-Review Started |
|
2026-01-09 09:59 |
|
First Decision by Editorial Office Director |
|
2026-01-20 09:21 |
|
Return for Revision |
|
2026-01-20 09:21 |
|
Revised |
|
2026-01-30 02:08 |
|
Publication Fee Transferred |
|
2026-02-03 07:57 |
|
Second Decision by Editor |
|
2026-03-17 03:07 |
 |
Second Decision by Editor-in-Chief |
|
|
|
Final Decision by Editorial Office Director |
|
2026-03-17 10:17 |
|
Articles in Press |
|
2026-03-17 10:17 |
|
Edit the Manuscript by Language Editor |
|
|
|
Typeset the Manuscript |
|
2026-04-30 06:56 |
|
Publish the Manuscript Online |
|
2026-05-06 08:34 |
| ISSN |
1007-9327 (print) and 2219-2840 (online) |
| Open Access |
This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution-NonCommercial (CC BY-NC 4.0) license. No commercial re-use. See Permissions. Published by Baishideng Publishing Group Inc. |
| Copyright |
©Author(s) (or their employer(s)) 2026. No commercial re-use. See Permissions. Published by Baishideng Publishing Group Inc. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Oncology |
| Manuscript Type |
Retrospective Study |
| Article Title |
Predictive value of neutrophil-lymphocyte ratio for prognosis in patients with advanced hepatocellular carcinoma treated with programmed cell death 1 inhibitors
|
| Manuscript Source |
Unsolicited Manuscript |
| All Author List |
Rui Guo and Meng Gao |
| ORCID |
|
| Funding Agency and Grant Number |
|
| Corresponding Author |
Rui Guo, Department of Laboratory Medicine, Henan Provincial People's Hospital, People's Hospital of Zhengzhou University, No. 7 Weiwu Road, Jinshui District, Zhengzhou 462000, Henan Province, China. guorui2460@163.com |
| Key Words |
Neutrophil-lymphocyte ratio; Hepatocellular carcinoma; Programmed cell death 1 inhibitor; Prognosis; Biomarker; Immunotherapy |
| Core Tip |
This study demonstrates that a high pretreatment neutrophil-lymphocyte ratio (NLR) is an independent predictor of poor response and survival in advanced hepatocellular carcinoma patients treated with programmed cell death 1 inhibitors. NLR reflects a systemic inflammatory state that may undermine immunotherapy efficacy. Our findings support the use of this simple, cost-effective biomarker for risk stratification and treatment personalization in the immunotherapy era. |
| Publish Date |
2026-05-06 08:34 |
| Citation |
Guo R, Gao M. Predictive value of neutrophil-lymphocyte ratio for prognosis in patients with advanced hepatocellular carcinoma treated with programmed cell death 1 inhibitors. World J Gastroenterol 2026; 32(18): 118416 |
| URL |
https://www.wjgnet.com/1007-9327/full/v32/i18/118416.htm |
| DOI |
https://dx.doi.org/10.3748/wjg.v32.i18.118416 |
All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.
